Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
25.49
+0.93 (3.79%)
At close: Aug 19, 2026, 4:00 PM EDT
25.99
+0.50 (1.96%)
After-hours: Aug 19, 2026, 7:43 PM EDT

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $71.55M in the quarter ending June 30, 2026, with 21.53% growth. This brings the company's revenue in the last twelve months to $308.08M, up 50.13% year-over-year. In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth.

Revenue (ttm)
$308.08M
Revenue Growth
+50.13%
P/S Ratio
13.20
Revenue / Employee
$493,720
Employees
624
Market Cap
4.07B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025276.98M98.02M54.77%
Dec 31, 2024178.96M8.68M5.10%
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 202098.38M13.31M15.65%
Dec 31, 201985.07M29.41M52.83%
Dec 31, 201855.66M17.22M44.77%
Dec 31, 201738.45M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RadNet2.27B
Qiagen2.10B
Sotera Health Company1.22B
NeoGenomics766.30M
Veracyte561.90M
CareDx458.09M
GeneDx Holdings454.43M
Twist Bioscience431.80M
Revenue Rankings